IL6 and diabetes mellitus: Human in vivo and in vitro studies have shown that patients with DM have impaired secretion of inflammatory cytokines (e.g., IL-6) after stimulation with lipopolysaccharide (LPS), which is part of the outer cell wall of gram-negative bacteria [25,26,27].